STK11 and neoplasm: This finding is not surprising, as LKB1 has been shown to promote physiological angiogenesis (Londesborough et al., 2008), whereas in cancer cells it acts as a tumor suppressor and inhibits angiogenesis (Zhuang et al., 2006).